Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jonathan M Friedman
Introduction
Jonathan M Friedman is a notable inventor based in Numazu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic conjugates. His work focuses on addressing critical health issues, including cancer.
Latest Patents
One of Jonathan's key patents is titled "Phosphatidylserine-binding conjugates." This patent presents conjugates capable of binding phosphatidylserine (PS) and toll-like receptors (TLRs). These conjugates have potential applications in the treatment of selected diseases and disorders, such as cancer. Jonathan holds 1 patent in this area, showcasing his innovative approach to medical challenges.
Career Highlights
Jonathan is currently associated with Canbas Co., Ltd., where he continues to advance his research and development efforts. His work at Canbas reflects his commitment to improving therapeutic options for patients.
Collaborations
Jonathan has collaborated with talented individuals such as Takumi Kawabe and Takuji Sato. These partnerships enhance the innovative potential of his projects and contribute to the advancement of their shared goals.
Conclusion
Jonathan M Friedman exemplifies the spirit of innovation in biotechnology through his groundbreaking work on phosphatidylserine-binding conjugates. His contributions are paving the way for new treatments in the medical field.